TNYA Stock Summary and Trading Ideas (Tenaya Therapeutics | NASDAQ:TNYA)

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.

Tenaya Therapeutics trades on the NASDAQ stock market under the symbol TNYA.

As of January 20, 2026, TNYA stock price declined to $0.72 with 1,985,539 million shares trading.

TNYA has a beta of 2.70, meaning it tends to be more sensitive to market movements. TNYA has a correlation of 0.10 to the broad based SPY ETF.

TNYA has a market cap of $155.88 million. This is considered a Micro Cap stock.

In the last 3 years, TNYA traded as high as $8.09 and as low as $.36.

The top ETF exchange traded funds that TNYA belongs to (by Net Assets): VTI, IBB, VXF, IBBQ, BIB.

TNYA has underperformed the market in the last year with a price return of -48.2% while the SPY ETF gained +16.7%. TNYA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -61.3% and -2.0%, respectively, while the SPY returned +3.7% and 0.0%, respectively.

TNYA support price is $.69 and resistance is $.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TNYA shares will trade within this expected range on the day.